These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32597829)

  • 1. Salt causes aging-associated hypertension via vascular Wnt5a under Klotho deficiency.
    Kawarazaki W; Mizuno R; Nishimoto M; Ayuzawa N; Hirohama D; Ueda K; Kawakami-Mori F; Oba S; Marumo T; Fujita T
    J Clin Invest; 2020 Aug; 130(8):4152-4166. PubMed ID: 32597829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
    Cao X; Luo T; Luo X; Tang Z
    Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho-associated kinase and zipper-interacting protein kinase, but not myosin light chain kinase, are involved in the regulation of myosin phosphorylation in serum-stimulated human arterial smooth muscle cells.
    Deng JT; Bhaidani S; Sutherland C; MacDonald JA; Walsh MP
    PLoS One; 2019; 14(12):e0226406. PubMed ID: 31834925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFTR deficiency aggravates Ang II induced vasoconstriction and hypertension by regulating Ca2+ influx and RhoA/Rock pathway in VSMCs.
    Zhao L; Yuan F; Pan N; Yu Y; Yang H; Liu Y; Wang R; Zhang B; Wang G
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1396-1410. PubMed ID: 34994155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Repressor of E1A-Stimulated Genes Is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II.
    Li Y; Liu Y; Tian X; Zhang Y; Song H; Liu M; Zhang X; Liu H; Zhang J; Zhang Q; Liu D; Peng C; Yan C; Han Y
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):485-494. PubMed ID: 28062494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney and epigenetic mechanisms of salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Nat Rev Nephrol; 2021 May; 17(5):350-363. PubMed ID: 33627838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy plays a critical role in Klotho gene deficiency-induced arterial stiffening and hypertension.
    Chen K; Sun Z
    J Mol Med (Berl); 2019 Nov; 97(11):1615-1625. PubMed ID: 31630227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of SIRT1 Attenuates Klotho Deficiency-Induced Arterial Stiffness and Hypertension by Enhancing AMP-Activated Protein Kinase Activity.
    Gao D; Zuo Z; Tian J; Ali Q; Lin Y; Lei H; Sun Z
    Hypertension; 2016 Nov; 68(5):1191-1199. PubMed ID: 27620389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
    Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
    J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Rho in Salt-Sensitive Hypertension.
    Kawarazaki W; Fujita T
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editing of the myosin phosphatase regulatory subunit suppresses angiotensin II induced hypertension via sensitization to nitric oxide mediated vasodilation.
    Htet M; Ursitti JA; Chen L; Fisher SA
    Pflugers Arch; 2021 Apr; 473(4):611-622. PubMed ID: 33145641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DP1 (Prostaglandin D
    Zou F; Li Y; Zhang S; Zhang J
    Hypertension; 2022 Jun; 79(6):1203-1215. PubMed ID: 35354317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage.
    Shen M; Morton J; Davidge ST; Kassiri Z
    J Mol Cell Cardiol; 2017 Feb; 103():11-21. PubMed ID: 27993561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells.
    Maltese G; Psefteli PM; Rizzo B; Srivastava S; Gnudi L; Mann GE; Siow RC
    J Cell Mol Med; 2017 Mar; 21(3):621-627. PubMed ID: 27696667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Yu L; Meng W; Ding J; Cheng M
    Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klotho Inhibits Proliferation and Migration of Angiotensin II-Induced Vascular Smooth Muscle Cells (VSMCs) by Modulating NF-κB p65, Akt, and Extracellular Signal Regulated Kinase (ERK) Signaling Activities.
    Yu S; Chen Y; Chen S; Ye N; Li Y; Sun Y
    Med Sci Monit; 2018 Jul; 24():4851-4860. PubMed ID: 30004089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
    Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
    Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus Causes Hypertension by Increasing Vascular Contractility via RhoA (Ras Homolog Family Member A)/ROCK (Rho-Associated Protein Kinase) Pathway in Mice.
    Wang X; Jiang S; Fei L; Dong F; Xie L; Qiu X; Lei Y; Guo J; Zhong M; Ren X; Yang Y; Zhao L; Zhang G; Wang H; Tang C; Yu L; Liu R; Patzak A; Persson PB; Hultström M; Wei Q; Lai EY; Zheng Z
    Hypertension; 2022 Oct; 79(10):2228-2238. PubMed ID: 35938417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
    Moriki N; Ito M; Seko T; Kureishi Y; Okamoto R; Nakakuki T; Kongo M; Isaka N; Kaibuchi K; Nakano T
    Hypertens Res; 2004 Apr; 27(4):263-70. PubMed ID: 15127884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM16A contributes to angiotensin II-induced cerebral vasoconstriction via the RhoA/ROCK signaling pathway.
    Li RS; Wang Y; Chen HS; Jiang FY; Tu Q; Li WJ; Yin RX
    Mol Med Rep; 2016 Apr; 13(4):3691-9. PubMed ID: 26955761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.